The browser doesnot support javascript
Print Plan Forms | Help

Medication Safety Alerts

AdrucilR 50 mg/mL vials Class I Recall

07/16/2015

On July 16, 2015, the United States Food and Drug Administration (FDA) issued a notice regarding Class I recall of Adrucil® 50 mg/mL vials. This recall was issued due to the presence of particulate matter identified as silicone rubber from the filler diaphragm. The use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote.

A complete list of the affected lot numbers is provided here.

Please note: This recall was originally issued on May 05, 2015 to the retail-level. The FDA classified this as a Class I Recall on July 16, 2015.

CVS/caremark Response: This product is not carried by the CVS/caremark Mail Service Pharmacies.

For more information about this recall, health care providers may contact Teva Medical Information at 1-888-838-2872. You may also call the FDA consumer inquiry line at 1‑888‑INFO‑FDA (1‑888‑463-6332) or visit their Web site at

www.accessdata.fda.gov/scripts.

The CVS/caremark™ app lets you manage your prescription benefits on the go. Download it now:

CVS Health LogoCVS Pharmacy LogoCVS Minute Clinic LogoCVS Specialty LogoSilverscript LogoAccordant Logo

Copyright © 2018 CVS/caremark. All rights reserved| Terms and Conditions | Privacy Policy | Accessibility | Member Rights & Responsibilities